AR044169A1 - Uso de derivados del acido fenoxiacetico para el tratamiento de la vejiga hiperactiva - Google Patents
Uso de derivados del acido fenoxiacetico para el tratamiento de la vejiga hiperactivaInfo
- Publication number
- AR044169A1 AR044169A1 ARP040101519A ARP040101519A AR044169A1 AR 044169 A1 AR044169 A1 AR 044169A1 AR P040101519 A ARP040101519 A AR P040101519A AR P040101519 A ARP040101519 A AR P040101519A AR 044169 A1 AR044169 A1 AR 044169A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- amino
- atom
- alkyl
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Campo de indicación para los derivados del ácido fenoxiacético descritos en la Solicitud de Patente Europea EP 1095932. los compuestos en ella descritos son adecuados para la preparación de un medicamento para tratar la vejiga hiperactiva (vejiga sobreactiva). En consecuencia, por medio de estas substancias activas se dispone de un método de tratamiento en este síndrome urológico. Formulación farmacéutica. Reivindicación 1: Uso de un compuesto de fórmula general (1) para preparar un medicamento para el tratamiento de la vejiga hiperactiva: donde X es un átomo de carbono quiral R o S; Y es un átomo de carbono quiral R o S; R1 es un grupo hidroxi, un grupo alcoxi C1-6, un grupo aril-alcoxi C1-6, un grupo amino primario o un grupo mono- o di(alquil C1-6)amino; uno de los grupos R2 y R3 es un átomo de H y el otro grupo es un átomo de H, un átomo de halógeno, un grupo alquilo C1-6, un grupo trifluorometilo o un grupo alcoxi C1-6, y R4 es un átomo de halógeno, un grupo alquilo C1-6, un grupo haloalquilo C1-6, un grupo hidroxi, un grupo alcoxi C1-6, un grupo aril-alcoxi C1-6, un grupo ciano, un grupo nitro, un grupo amino, un grupo mono- o di(alquil C1-6)amino, un grupo carbamoílo o un grupo mono- o di(alquil C1-6)carbamoílo, o corresponde al grupo -NHCOR5, donde R5 es un átomo de H o un grupo alquilo C1-6; o una sal del mismo farmacéuticamente aceptable. Reivindicación 8: Uso según la reivindicación 1, caracterizado porque el compuesto es 2-[4-(2-{[(1S, 2R)-2-hidroxi-2-(4-hidroxifenil)-1-metiletil]amino}etil)-2,5-dimetilfenoxi] acetato de (-)-etilo, clorhidrato de 2-[4-(2-{[(1S, 2R)-2-hidroxi-2-(4-hidroxifenil)-1-metiletil]-amino}etil)-2,5-dimetilfenoxi]acetato de (-)-etilo o ácido (-)-2-[4-(2-{[(1S, 2R)-2-hidroxi-2-(4-hidroxifenil)-1-metiletil]amino}etil)-2,5-dimetilfenoxi]acético.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10320084A DE10320084A1 (de) | 2003-05-05 | 2003-05-05 | Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase |
| DE2003123837 DE10323837A1 (de) | 2003-05-23 | 2003-05-23 | Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044169A1 true AR044169A1 (es) | 2005-08-24 |
Family
ID=33420009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101519A AR044169A1 (es) | 2003-05-05 | 2004-05-05 | Uso de derivados del acido fenoxiacetico para el tratamiento de la vejiga hiperactiva |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20040229947A1 (es) |
| EP (1) | EP1620085B1 (es) |
| JP (1) | JP4602969B2 (es) |
| KR (1) | KR101052804B1 (es) |
| AR (1) | AR044169A1 (es) |
| AT (1) | ATE401878T1 (es) |
| AU (1) | AU2004236596B2 (es) |
| BR (1) | BRPI0409980A (es) |
| CA (1) | CA2524023C (es) |
| CL (1) | CL2004000952A1 (es) |
| CY (1) | CY1108425T1 (es) |
| DE (1) | DE602004015272D1 (es) |
| DK (1) | DK1620085T3 (es) |
| ES (1) | ES2309513T3 (es) |
| IL (1) | IL171713A (es) |
| MX (1) | MXPA05011862A (es) |
| MY (1) | MY141756A (es) |
| NZ (1) | NZ543347A (es) |
| PE (1) | PE20050524A1 (es) |
| PL (1) | PL1620085T3 (es) |
| PT (1) | PT1620085E (es) |
| RU (1) | RU2342133C2 (es) |
| SI (1) | SI1620085T1 (es) |
| TW (1) | TWI351279B (es) |
| UY (1) | UY28306A1 (es) |
| WO (1) | WO2004098586A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI356699B (en) * | 2004-11-10 | 2012-01-21 | Kissei Pharmaceutical | Agent for treating interstitial cystitis and agent |
| WO2006118087A1 (ja) * | 2005-04-26 | 2006-11-09 | Kissei Pharmaceutical Co., Ltd. | ヒドロキシノルエフェドリン誘導体塩酸塩・１／４水和物の結晶 |
| EP1878719A4 (en) * | 2005-04-26 | 2010-10-06 | Kissei Pharmaceutical | HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL |
| EP1769792A1 (de) * | 2005-09-30 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden |
| EP3634420A1 (en) | 2017-06-06 | 2020-04-15 | Urovant Sciences GmbH | Use of vibegron to treat overactive bladder |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
| US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
| US6720014B1 (en) * | 1997-08-13 | 2004-04-13 | Diversa Corporation | Phytase-containing foodstuffs and methods of making and using them |
| MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| DE60041110D1 (de) * | 1999-11-01 | 2009-01-29 | Sumitomo Chemical Co | 6-Hydroxy-5,6-dihydrouracile als Herbizide |
| UA77000C2 (en) * | 2001-09-13 | 2006-10-16 | Kissei Pharmaceutical | Crystalline form of hydroxynorephedrine derivative |
-
2004
- 2004-03-24 DK DK04722967T patent/DK1620085T3/da active
- 2004-03-24 KR KR1020057020792A patent/KR101052804B1/ko not_active Expired - Fee Related
- 2004-03-24 PT PT04722967T patent/PT1620085E/pt unknown
- 2004-03-24 PL PL04722967T patent/PL1620085T3/pl unknown
- 2004-03-24 NZ NZ543347A patent/NZ543347A/en not_active IP Right Cessation
- 2004-03-24 BR BRPI0409980-0A patent/BRPI0409980A/pt not_active IP Right Cessation
- 2004-03-24 JP JP2006507687A patent/JP4602969B2/ja not_active Expired - Fee Related
- 2004-03-24 MX MXPA05011862A patent/MXPA05011862A/es active IP Right Grant
- 2004-03-24 SI SI200430884T patent/SI1620085T1/sl unknown
- 2004-03-24 EP EP04722967A patent/EP1620085B1/en not_active Expired - Lifetime
- 2004-03-24 ES ES04722967T patent/ES2309513T3/es not_active Expired - Lifetime
- 2004-03-24 RU RU2005137701/15A patent/RU2342133C2/ru not_active IP Right Cessation
- 2004-03-24 DE DE602004015272T patent/DE602004015272D1/de not_active Expired - Lifetime
- 2004-03-24 AU AU2004236596A patent/AU2004236596B2/en not_active Ceased
- 2004-03-24 WO PCT/JP2004/004048 patent/WO2004098586A1/en not_active Ceased
- 2004-03-24 CA CA2524023A patent/CA2524023C/en not_active Expired - Fee Related
- 2004-03-24 AT AT04722967T patent/ATE401878T1/de active
- 2004-03-26 US US10/809,346 patent/US20040229947A1/en not_active Abandoned
- 2004-04-21 TW TW093111093A patent/TWI351279B/zh not_active IP Right Cessation
- 2004-04-30 MY MYPI20041651A patent/MY141756A/en unknown
- 2004-05-04 CL CL200400952A patent/CL2004000952A1/es unknown
- 2004-05-05 PE PE2004000459A patent/PE20050524A1/es not_active Application Discontinuation
- 2004-05-05 UY UY28306A patent/UY28306A1/es unknown
- 2004-05-05 AR ARP040101519A patent/AR044169A1/es not_active Application Discontinuation
-
2005
- 2005-11-01 IL IL171713A patent/IL171713A/en not_active IP Right Cessation
-
2008
- 2008-10-16 CY CY20081101158T patent/CY1108425T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL171713A (en) | 2011-12-29 |
| TWI351279B (en) | 2011-11-01 |
| CA2524023C (en) | 2011-11-22 |
| BRPI0409980A (pt) | 2006-05-09 |
| KR20060009886A (ko) | 2006-02-01 |
| RU2005137701A (ru) | 2006-06-10 |
| NZ543347A (en) | 2008-05-30 |
| EP1620085B1 (en) | 2008-07-23 |
| RU2342133C2 (ru) | 2008-12-27 |
| MY141756A (en) | 2010-06-30 |
| WO2004098586A1 (en) | 2004-11-18 |
| EP1620085A1 (en) | 2006-02-01 |
| UY28306A1 (es) | 2004-12-31 |
| AU2004236596A1 (en) | 2004-11-18 |
| PE20050524A1 (es) | 2005-07-07 |
| MXPA05011862A (es) | 2006-02-17 |
| US20040229947A1 (en) | 2004-11-18 |
| JP2006525318A (ja) | 2006-11-09 |
| KR101052804B1 (ko) | 2011-07-29 |
| DK1620085T3 (da) | 2008-11-24 |
| ATE401878T1 (de) | 2008-08-15 |
| PT1620085E (pt) | 2008-08-07 |
| JP4602969B2 (ja) | 2010-12-22 |
| CA2524023A1 (en) | 2004-11-18 |
| SI1620085T1 (sl) | 2008-12-31 |
| ES2309513T3 (es) | 2008-12-16 |
| CY1108425T1 (el) | 2014-04-09 |
| PL1620085T3 (pl) | 2009-01-30 |
| CL2004000952A1 (es) | 2005-03-04 |
| TW200509902A (en) | 2005-03-16 |
| AU2004236596B2 (en) | 2010-03-11 |
| DE602004015272D1 (de) | 2008-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2445312C2 (ru) | ПРОИЗВОДНЫЕ 2-МЕТИЛМОРФОЛИН ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR | |
| RU2374241C2 (ru) | N-ацилированные азотсодержащие гетероциклические соединения в качестве лигандов ppar-рецепторов, активируемых пролифератором пероксисомы | |
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| RU2010141823A (ru) | Соединения и способ снижения мочевой кислоты | |
| RU2007132161A (ru) | Замещенные ариламины и их применение в качестве модуляторов 5-ht6-рецептора | |
| RU2008142834A (ru) | Модуляция церамидкиназы | |
| RU2008146816A (ru) | Фармацевтическая комбинация, содержащая 3-(3-диметиламино-1-этил-2-метилпропил)фенол и парацетамол | |
| RU2367650C2 (ru) | Циклоалкендикарбоновые кислоты как противовоспалительные, иммуномодулирующие и антипролиферативные средства | |
| RU2009136592A (ru) | Терапевтические агенты | |
| JP2004533450A5 (es) | ||
| RU2007106180A (ru) | Производные индола, индазола или индолина | |
| KR960041168A (ko) | 베타-아드레날린 효능성 작용물질 | |
| BR112018069930B1 (pt) | Compostos agonistas de ppar, uso dos mesmos e composição farmacêutica | |
| JP2005532331A5 (es) | ||
| JP2017509694A5 (es) | ||
| CA2458544A1 (en) | Crystals of hydroxynorephedrine derivative | |
| RU2009114544A (ru) | Производные пиридина для лечения метаболических нарушений, связанных с устойчивостью к действию инсулина или гипергликемией | |
| RU2004101229A (ru) | Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения | |
| JP2005532397A5 (es) | ||
| RU2006108572A (ru) | Соединения для лечения метаболических нарушений | |
| AR044169A1 (es) | Uso de derivados del acido fenoxiacetico para el tratamiento de la vejiga hiperactiva | |
| RU2009146132A (ru) | Карбамоилоксиарилалканоиларилпиперазиновое соединение, фармацевтические композиции, содержащие его, и способ лечения боли, беспокойства и депрессии | |
| JP2008530242A5 (es) | ||
| RU2008129723A (ru) | Ингибиторы ccr9 активности | |
| JP2007518798A5 (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |